Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 24,897 shares at $47.22 ($1.2M) on 2007-09-12, disclosed to the SEC on 2007-09-14.
Open-market sale of $1.2M MYGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.00 | 602 | $28K | 2.4% |
| 2 | $47.00 | 1,898 | $89K | 7.6% |
| 3 | $47.20 | 5,000 | $236K | 20.1% |
| 4 | $47.21 | 2,500 | $118K | 10.0% |
| 5 | $47.22 | 2,100 | $99K | 8.4% |
| 6 | $47.22 | 400 |
| $19K |
| 1.6% |
| 7 | $47.23 | 5,000 | $236K | 20.1% |
| 8 | $47.24 | 2,897 | $137K | 11.6% |
| 9 | $47.03 | 200 | $9K | 0.8% |
| 10 | $47.06 | 600 | $28K | 2.4% |
| 11 | $47.07 | 700 | $33K | 2.8% |
| 12 | $47.56 | 500 | $24K | 2.0% |
| 13 | $47.57 | 500 | $24K | 2.0% |
| 14 | $47.63 | 500 | $24K | 2.0% |
| 15 | $47.65 | 1,500 | $71K | 6.1% |
| Total | $47.24 avg | 24,897 | $1.2M | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |